Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascularization (GAIN I) trial-Reference-Cited by-同舟云学术

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascularization (GAIN I) trial

Published:2008-11 Issue:5 Volume:156 Page:954-963
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kovacic Jason C.,Macdonald Peter,Feneley Michael P.,Muller David W.M.,Freund Judith,Dodds Anthony,Milliken Sam,Tao Helen,Itescu Silviu,Moore John,Ma David,Graham Robert M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease;Kovacic;J Mol Cell Cardiol,2007

2. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease;Suzuki;Circ J,2006

3. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease;Wang;Int J Cardiol,2005

4. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease;Hill;J Am Coll Cardiol,2005

5. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up;Boyle;Int J Cardiol,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chasing c-Kit through the heart: Taking a broader view;Pharmacological Research;2018-01

2. COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133(+) Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial;CELL J;2018

3. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease;World Journal of Stem Cells;2017-12-26

4. Hydrogel based approaches for cardiac tissue engineering;International Journal of Pharmaceutics;2017-05

5. New vessel formation in the context of cardiomyocyte regeneration – the role and importance of an adequate perfusing vasculature;Stem Cell Research;2014-11